Non-invasive monitoring to improve patient care in nursing facilities
Impact of Non-invasive Continuous Patient Monitoring System on Patient Management and Health Outcomes
Turtle Shell Technologies Pvt. Ltd. · NCT06270953
This study is testing a new system that continuously checks vital signs in nursing homes to see if it can help improve patient care and make healthcare more efficient.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Months to 120 Years |
| Sex | All |
| Sponsor | Turtle Shell Technologies Pvt. Ltd. (industry) |
| Locations | 1 site (Lake Jackson, Texas) |
| Trial ID | NCT06270953 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of the Dozee Pro NX system, which provides continuous non-invasive monitoring of vital signs in skilled nursing facilities (SNFs) and assisted living facilities (ALFs). By addressing the challenges of infrequent vital sign checks, the study aims to enhance patient outcomes, improve practitioner efficiency, and reduce healthcare costs. The system alerts healthcare providers to changes in vital signs, allowing for timely interventions and potentially preventing adverse health events. The study focuses on understanding how this technology can fill gaps in patient monitoring and care delivery.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who weigh between 40kg and 120kg and reside in skilled nursing or assisted living facilities.
Not a fit: Patients with terminal illnesses, those who cannot lie flat, or individuals who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved patient outcomes and reduced adverse events in nursing facilities.
How similar studies have performed: While this approach is innovative, similar studies have shown that continuous monitoring can significantly improve patient outcomes in healthcare settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older. * Weight between 40kg-120kgs Exclusion Criteria: * Terminal illness with a life expectancy of less than 1 month. * Have any condition that could interfere with the subject's ability to lie flat or stable on the bed * Needs the use of equipment whose operation can interfere with Investigation System operations * Patients planned to be transferred from the facility within 72 hours * Prisoners * Pregnant
Where this trial is running
Lake Jackson, Texas
- Oak Village Healthcare — Lake Jackson, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Lindsay Darthard, LNFA — Oak Village Healthcare
- Study coordinator: Lindsay Darthard, LNFA
- Email: lindsaydarthard@gcltc.com
- Phone: 979-319-2306
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: No Specific Medical Conditions or Disease States